Minnesota SF 4084: Prescription Drug Price Transparency Act

Status: Referred to Health and Human Services Finance and Policy (as of 2020-03-05)

State: Minnesota · Session: 2019-2020 · Bill: SF 4084

Subjects: Commerce and Commerce Department, Consumer Protection, Drugs and Medicine, Health and Health Department, Popular Names

Sponsors: Jensen, Eaton, Kent, Lang, Marty

View Minnesota SF 4084 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.